This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Isaza, D. M. Articles by Mosca, W. Search for Related Content PubMed PubMed Citation Articles by Isaza, D. M. Articles by Mosca, W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 12 1997, 3043-3047, Vol 35, No. 12
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis [In Process Citation]

DM Isaza, M Restrepo and W Mosca
Instituto Colombiano de Medicina Tropical, Medellin, Columbia. icmt@janua.upb.edu.co

Sera from 86 Colombian patients with parasitologically confirmed cutaneous leishmaniasis were studied by immunoblot analysis in order to identify a specific pattern for Leishmania infection. A soluble extract of Leishmania panamensis was used as the antigen. Sera from patients with Chagas' disease and sera from patients with no record of infection with trypanosomatids were also studied. The sera from patients with cutaneous leishmaniasis specifically recognized fractions of 120 kDa (76.7%), 123 and 129 kDa (69.7%), 138 kDa (61.6%), 141 kDa (53.4%), and 78 kDa (44.1%). No band common to all patients infected with Leishmania parasites was found at the time of diagnosis. Likewise, the pattern of immunoblot change after the patients were treated and apparently cured with meglumine antimoniate (Glucantime) was studied by evaluating sera pretreatment and 1 year posttreatment. Only minor changes in the color intensity at the same serum dilution between pre- and posttreatment sera were found, although the antibody titers by indirect immunofluorescence were negative for the posttreatment sample. This study shows that Western blot analysis is a more sensitive test for the detection of anti-Leishmania antibodies. However, the importance of whether the presence of antibodies correlates with the presence of Leishmania antigens could not be resolved by the data obtained from this study.

This article has been cited by other articles:

• Zeyrek, F. Y., Korkmaz, M., Ozbel, Y. (2007). Serodiagnosis of Anthroponotic Cutaneous Leishmaniasis (ACL) Caused by Leishmania tropica in Sanliurfa Province, Turkey, Where ACL Is Highly Endemic. CVI 14: 1409-1415 [Abstract] [Full Text]  
• Kumar, P., Pai, K., Tripathi, K., Pandey, H. P., Sundar, S. (2002). Immunoblot Analysis of the Humoral Immune Response to Leishmania donovani Polypeptides in Cases of Human Visceral Leishmaniasis: Its Usefulness in Prognosis. CVI 9: 1119-1123 [Abstract] [Full Text]  
• Ryan, J. R., Smithyman, A. M., Rajasekariah, G-H., Hochberg, L., Stiteler, J. M., Martin, S. K. (2002). Enzyme-Linked Immunosorbent Assay Based on Soluble Promastigote Antigen Detects Immunoglobulin M (IgM) and IgG Antibodies in Sera from Cases of Visceral and Cutaneous Leishmaniasis. J. Clin. Microbiol. 40: 1037-1043 [Abstract] [Full Text]  
• Brito, M. E. F., Mendonca, M. G., Gomes, Y. M., Jardim, M. L., Abath, F. G. C. (2000). Identification of Potentially Diagnostic Leishmania braziliensis Antigens in Human Cutaneous Leishmaniasis by Immunoblot Analysis. CVI 7: 318-321 [Abstract] [Full Text]